You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API PRAVASTATIN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing PRAVASTATIN SODIUM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ER Squibb & Sons LLC PRAVACHOL pravastatin sodium 0003-5178 CELLULOSE, MICROCRYSTALLINE
ER Squibb & Sons LLC PRAVACHOL pravastatin sodium 0003-5178 CROSCARMELLOSE SODIUM
ER Squibb & Sons LLC PRAVACHOL pravastatin sodium 0003-5178 FERRIC OXIDE YELLOW
ER Squibb & Sons LLC PRAVACHOL pravastatin sodium 0003-5178 LACTOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing PRAVASTATIN SODIUM

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc pravastatin sodium 0093-0771 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Teva Pharmaceuticals USA Inc pravastatin sodium 0093-0771 ANHYDROUS LACTOSE
Teva Pharmaceuticals USA Inc pravastatin sodium 0093-0771 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc pravastatin sodium 0093-0771 CROSCARMELLOSE SODIUM
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for PRAVASTATIN SODIUM

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BLUE 1

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 42090

Excipient focus: CI 47005

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM ALUMINUM SILICATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MEGLUMINE

Excipient focus: METHYLGLUCAMINE

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYOXYL 35 CASTOR OIL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: POWDERED CELLULOSE

Excipient focus: SAND

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CARBONATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: YELLOW 10

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links